These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15900630)

  • 1. HIV and insulin resistance in context.
    Kotler DP
    AIDS Read; 2005 May; 15(5):220. PubMed ID: 15900630
    [No Abstract]   [Full Text] [Related]  

  • 2. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Deviating from classical triple therapy. Nuke sparing concepts as interest focus].
    MMW Fortschr Med; 2011 May; 153(18):38. PubMed ID: 21604594
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stigmatization, metabolic trouble, drug resistance: current challenges in HIV therapy].
    Mauss S; Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):28. PubMed ID: 19769068
    [No Abstract]   [Full Text] [Related]  

  • 5. [How to minimize the secondary effects of antiretrovirals].
    Cernadas R
    Sidahora; 2003; (1):8-17. PubMed ID: 12733497
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-associated lipoatrophy: what are the kinder, gentler agents?
    Dubé MP
    Clin Infect Dis; 2006 Jan; 42(2):281-2. PubMed ID: 16355342
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
    Sattler FR
    Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipodystrophic syndromes in HIV-infected patients receiving antiretroviral treatment].
    Simeoni J
    Ann Endocrinol (Paris); 2003 Dec; 64(6):490-1. PubMed ID: 15080164
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV lipodystrophy: where are we after ten years?
    Vergel N
    GMHC Treat Issues; 2007; 21(3-4):10-5. PubMed ID: 19230305
    [No Abstract]   [Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma agonists and the treatment of HIV-associated lipoatrophy: unraveling the molecular mechanism of their shortcomings.
    Hadigan C
    J Infect Dis; 2008 Dec; 198(12):1729-31. PubMed ID: 18954262
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.
    Mallewa JE; Wilkins E; Vilar J; Mallewa M; Doran D; Back D; Pirmohamed M
    J Antimicrob Chemother; 2008 Oct; 62(4):648-60. PubMed ID: 18565973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side effects of antiretroviral therapy--skin manifestations].
    Esser S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():8, 10-1. PubMed ID: 19024907
    [No Abstract]   [Full Text] [Related]  

  • 15. ART regimes and fat: the healing hand wielding the sword.
    Domingo P; Espinet J; Vidal F
    Lancet HIV; 2017 Jan; 4(1):e2-e3. PubMed ID: 27815067
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention and therapy of HIV-associated lipodystrophy syndrome and antiretroviral caused metabolic changes].
    Mauss S
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():49-53. PubMed ID: 16385875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipodystrophy: lack of agreement on definition and etiology presents a challenge to research and therapy.
    Moyle G
    AIDS Read; 2002 Oct; 12(10):438, 440-2. PubMed ID: 12408100
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of zidovudine in development of lipoatrophy.
    Moyle GJ
    AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181
    [No Abstract]   [Full Text] [Related]  

  • 19. The experts speak. Metabolic complications associated with HIV infection and antiretroviral therapy. Interview by Vicki Glaser.
    Powderly W
    AIDS Patient Care STDS; 2004 Aug; 18(8):431-5. PubMed ID: 15321014
    [No Abstract]   [Full Text] [Related]  

  • 20. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.